Skip to main content
Retour
Watch Compare

Q32 Bio Inc.

Qualité des données : 100%
QTTB
Nasdaq Manufacturing Chemicals
5,05 €
▲ 0,13 € (2,64%)
Cap. Boursière: 72,42 M
Prix
4,95 €
Cap. Boursière
72,42 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 12,15% annually over 5 years — strong growth
Net margin of 55,49% shows strong profitability
Negative free cash flow of -33,54 M
P/E of 2,43 — trading at a low valuation
Capital efficient — spends only 0,00% of revenue on capex
ROIC of 33,38% — excellent capital efficiency

Croissance

Revenue Growth (5Y)
12,15%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC33,38%
Net Margin55,49%
Op. Margin31,45%

Sécurité

Debt / Equity
N/A
Current Ratio4,57
Interest Coverage16,02

Valorisation

PE (TTM)
2,43
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDA1,38
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 2,4 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % 55,5 -41,5
Rev Growth 5Y % 12,2 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) 581,80%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12,15% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 53,74 M Net Income (TTM) 29,82 M
ROE N/A ROA 48,14%
Gross Margin N/A Operating Margin 31,45%
Net Margin 55,49% Free Cash Flow (TTM) -33,54 M
ROIC 33,38% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,57
Interest Coverage 16,02 Asset Turnover 0,87
Working Capital 39,70 M Tangible Book Value -18,45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2,43 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1,38 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -46,32%
Market Cap 72,42 M Enterprise Value 23,38 M
Per Share
EPS (Diluted TTM) 2,42 Revenue / Share 3,67
FCF / Share -2,29 OCF / Share -2,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion -112,48%
SBC-Adj. FCF -38,71 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 53,74 M 0,0 1,16 M 3,21 M 33,97 M
Net Income 29,82 M -47,73 M -112,96 M -5,01 M -95,76 M
EPS (Diluted) 2,42 -6,58 -1,95 -0,09 —
Gross Profit — — — — —
Operating Income 16,90 M -66,10 M -101,43 M -133,28 M -95,95 M
EBITDA — — — — —
R&D Expenses 19,16 M 48,14 M 62,00 M 98,35 M 93,09 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1,06 M 1,50 M — — —
Income Tax 0,0 21 000,0 0,0 715 000,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 61,78 M 92,33 M 84,56 M 228,47 M 211,72 M
Total Liabilities 19,76 M 86,66 M 11,57 M 50,49 M 42,07 M
Shareholders' Equity 42,01 M 5,68 M 72,99 M 177,98 M 169,65 M
Total Debt — — — — —
Cash & Equivalents 48,30 M 77,97 M 39,27 M 33,99 M 108,38 M
Current Assets 55,05 M 81,88 M 83,91 M 181,02 M 191,91 M
Current Liabilities 11,35 M 16,47 M 11,57 M 22,58 M 17,23 M